AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide.
AccuLine is developing CORA—a smart, accurate, and easy to use exam for the early detection of coronary artery disease.
The clinically validated CORA evaluates a patient’s risk of having coronary artery disease through advanced analysis and detection of two newly discovered biomarkers in the heart’s electrical activity. CORA’s early detection will assist in the prevention of sudden cardiac deaths, while lowering costs of cardiovascular related illness.
AccuLine has received a grant from the Israeli Innovation Authority and is a portfolio company of eHealth Ventures—founded by Maccabi Health Services, backed by Amgen, Medison Ventures, SCI (Shanghai Creation Investment), and partnered with Mayo Clinic.
Company’s Keywords:
cardiology, cardiology & medical device
<1
<
<